Venture Investors is a venture capital firm that specializes in funding innovative startups, particularly in the healthcare and technology sectors. The firm has a history of investing in early-stage companies and helping them grow through strategic investments and guidance.

Venture Investors

Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare. Today, we have over $200 million in assets under management.

Silatronix

Aerpio Pharmaceuticals

Cellectar Biosciences

Akebia Therapeutics

Celleration

ReShape Lifesciences

Third Wave Technologies

Virent Energy Systems

NeuMoDx Molecular

Neurovance

NeuWave Medical

"We are delighted to have our pivotal trial fully enrolled with a total of 152 patients," said Tibor Juhasz, PhD, Founder and Chief Executive Officer, ViaLase, Inc..."Ultimately, it is our greatest wish to be able to provide an effective noninvasive treatment to the millions of people living with glaucoma, one of the leading causes of irreversible blindness worldwide."

Congratulations to Justin Mortara, Ph.D., Chris Fernandez, and the EnsoData team on this exciting partnership.

Great data from #Histosonics. Very safe and high techical success. Wonderful for patients. #ventureinvestors.

James (Jim) Adox, the chair of the board of directors of HistoSonics, Inc., will join the head of the U-M histotripsy research group and leaders from Michigan Medicine on the panel.

“Mammography alone is not enough to address the screening needs of dense breast patients,” said Mark J Forchette, president and CEO of Delphinus Medical Technologies. “SoftVue provides a comprehensive solution that enables providers to transform their patients’ clinical experience...and serve the unmet needs of patients with dense breast tissue that SoftVue was designed to address.” https://lnkd.in/g_4cubVi

"The round, oversubscribed and co-led by Flare Capital Partners and Frist Cressey Ventures, also saw participation from InHealth Ventures, Oxeon Partners, Pixel Perfect Ventures, Venture Investors, among others. Visana’s investors and the organizations they represent comprise over 30 of the nation’s leading healthcare organizations. They recognize that evidence-based, digital platforms like the one Visana offers are the best way to provide the comprehensive, clinical, and value-focused care women so desperately need." https://lnkd.in/eptEb4Ym

“Most women’s health solutions focus narrowly on maternity and fertility, missing the mark for the 90% of women who aren’t actively building a family,” said Shelly Lanning, co-founder and president, Visana. “We built Visana to provide women with in-depth care for all phases of life.”
https://lnkd.in/gvF3xger

Congrats to Erica Rogers on her well-deserved honor at this year's #MedtechMVP conference. And great job by James (Jim) Adox.

COM:VENTUREINVESTORS

Venture Investors